Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Nanomaterials for Smart Therapeutic Treatments"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 42687
Special Issue Editors
Interests: bionanotechnology; nanotechnology; nanomedicine; virus-like particles; virus; capsids
E-Mail Website1 Website2 Website3
Interests: nanotoxicology; bionanotechnology; biomedicine; nanomedicine; metallic nanoparticles; smart nanomaterials for therapeutics
Interests: deep eutectic solvents; macroporous polymers; high internal phase emulsions; nanocomposites; nanoparticles; green chemistry; sustainability
Special Issue Information
As a consequence of multidrug-resistance, administration of high-doses of anticancer drugs is required, often generating undesired toxicity. The active delivery of anticancer drugs into tumors has been exploited through the use of nanocarriers. In addition, the use of smart nanobioreactors functionalized in tandem with drugs and other catalytic molecules has improved the drug activity to treat chronic diseases. Both strategies aim to reduce the systemic side effects of anticancer drugs. To further reduce both the dose and the side effects of drugs, it is necessary to optimize their therapeutic effect through chemotherapy and antiproliferative-nanomaterials' synergistic combinatorial activity.
It is expected that the judicious combination of nanomaterials with biomolecules and drugs, acting in synergy, significantly improve the antitumor activity to cope with the challenges of multidrug-resistant cancer cells and other pathologies. This strategy will pave the way for innovative approaches to improve the therapeutic effect of known drugs.
This Special Issue aims to highlight recent advances in nanomaterials' synergistic effects with various molecules, including drugs.
We welcome contributions in the form of reviews and original research on topics dealing with the potentiation of the biological activity of nanomaterials in combination with drugs, enzymes, and other biomolecules in the following fields but not limited to:
- Nanomaterials for cancer therapy and diagnosis
- Smart nanomaterials
- Synergistic effects of nanoparticles in combination with anticancer drugs
- Therapeutic combination of nanomaterials
- Functionalized nanomaterials for tissue engineering
- Enzyme-delivery through nanomaterials
- Study on molecular mechanisms of nanomaterials using in vitro and in vivo models
- Nanomaterials for smart therapeutic treatments
Prof. Dr. Rafael Vazquez-Duhalt
Dr. Josué D. Mota-Morales
Dr. Karla Juarez-Moreno
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- smart nanomaterials
- anticancer drugs